Showing results (41-50 of 358) with videos related to
Sort By:
Pageof 36
Seminars in Oncology|December 10, 2003
Estrogen deficiency symptom management in breast cancer survivors in the changing context of menopausal hormone therapyRowan T Chlebowski, Jung A Kim, Nananda F ColBreast Cancer Research : BCR|July 1, 2005
Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidenceNananda F Col, Jung A Kim, Rowan T ChlebowskiMenopause (New York, N.Y.)|August 15, 2022
Estrogen therapy and breast cancer in randomized clinical trials: a narrative reviewKathy Pan, Sayeh Lavasani, Aaron K Aragaki, et al.Clinical Breast Cancer|April 6, 2006
Coronary heart disease and stroke with aromatase inhibitor, tamoxifen, and menopausal hormone therapy useRowan T Chlebowski, Garnet L Anderson, Michelle Geller, et al.Oncotarget|May 30, 2019
Weight loss, diet composition and breast cancer incidence and outcome in postmenopausal womenKathy Pan, Juhua Luo, Aaron K Aragaki, et al.The International Journal of Biostatistics|October 25, 2012
Invited commentary on Pearl and principal stratificationRoss PrenticeClinical Trials (London, England)|September 14, 2010
Prospective evaluation of two recruitment strategies for a randomized controlled cancer prevention trialRowan T Chlebowski, Rashmi Menon, Roslyn M Chaisanguanthum, et al.Breast Cancer Research and Treatment|January 20, 2019
Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivorsXiaoqing Xu, Rowan T Chlebowski, Jiaxiao Shi, et al.Journal of the National Cancer Institute|March 17, 2005
Ethnicity and breast cancer: factors influencing differences in incidence and outcomeRowan T Chlebowski, Zhao Chen, Garnet L Anderson, et al.Cancer|March 27, 2020
Forty-year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white womenRowan T Chlebowski, Aaron K Aragaki, Garnet L Anderson, et al.Pageof 36